Patent · US Active

Methods and compositions for treating hemophilia B

US9175280B2 · kind B2 · utility

8Cited by
35References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 12, 2011
Grant dateNov 3, 2015
Priority date
Expiry dateAug 24, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/0661
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for insertion of Factor IX (FIX) sequences into the genome of a cell for treating hemophilia B.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.